-2%
Betmira ER Tablet is indicated for the symptomatic treatment of urgency, increased urinary frequency, and urge incontinence commonly seen in adult patients with Overactive Bladder (OAB) syndrome.
Mirabegron, the active ingredient in Betmira ER, is the first β3-adrenoceptor agonist. It acts by a dual mechanism—directly relaxing the smooth muscle of the bladder and influencing the sensory nervous system.
Activation of β3-adrenoceptors increases cyclic adenosine monophosphate (cAMP) levels, leading to relaxation of the detrusor muscle during the bladder’s storage phase, thereby enhancing bladder capacity and reducing symptoms of OAB.